News
20h
New York Magazine on MSNJohnson Does a Full 180 on Epstein Files After Hearing ‘the President’s Heart’The Speaker had said he wanted full transparency, but now he’s shut down the House to spare Trump from such demands.
Johnson & Johnson (NYSE:JNJ) is one of the stocks that Jim Cramer shed light on. Cramer was incredibly bullish on the company ...
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...
Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...
Johnson says he wants to put social workers at stops and launch an anti-smoking campaign. A council member who’s pushed for ...
1h
InvestorsHub on MSNJohnson & Johnson’s Darzalex approved in EU for high-risk smouldering myelomaJohnson & Johnson (NYSE:JNJ) announced Wednesday that the European Commission has granted approval for its Darzalex ...
2d
Zacks Investment Research on MSNJohnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is ...
1don MSN
It wasn't perfect for Johnson, who struggled in one of his five summer league games to total just five points on 2-of-10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results